Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News OS Therapies Inc OSTX

Healthcare Biotechnology
OS Therapies Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. It built a pipeline of product candidates targeting multiple indications for solid cancers. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. OST-HER2 is an off-the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:OSTX)

OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates

Business Wire 4 days ago

OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models

Accesswire 6 days ago

OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference

Business Wire 12 days ago

OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose

Business Wire August 29, 2024

OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board

Business Wire August 22, 2024

OS Therapies Clarifies CUSIP of Common Stock

Business Wire August 22, 2024

OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS

Business Wire August 19, 2024

OS Therapies Reports Second Quarter 2024 Financial Results

Accesswire August 15, 2024

OS Therapies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire August 9, 2024
View More News ››

Opinion & Analysis (NYSEAM:OSTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:OSTX)

Investors Beware: The Fed, Trump, and the Volatility

Investors Beware: The Fed, Trump, and the Volatility That Could Rock Your Portfolio (NYSE-A: OSTX) https://10xalerts.com/investors...
Mathew177 - September 3, 2024

OS Therapies Pioneers Hope for Osteosarcoma Patients

OS Therapies Pioneers Hope for Osteosarcoma Patients (NYSE-A: OSTX) ...
Mathew177 - August 22, 2024

The Future of Medicine: Key Biotech Stocks to Watch

The Future of Medicine: Key Biotech Stocks to Watch ($OSTX , $CRBP , $PBYI , $ATNM ) ...
Mathew177 - August 21, 2024

Investment Opportunities in a Shifting Market (NYSE-A: OSTX)

Investment Opportunities in a Shifting Market: Rate Cuts and One Stock Pick (NYSE-A: OSTX) https://10xalerts.com/investment-opportunities...
Brice978 - August 16, 2024

A Potential Game-Changer for Osteosarcoma $OSTX

OSTX's OST-HER2: A Potential Game-Changer for Osteosarcoma (NYSE-A: OSTX) ...
ElliotGH - August 15, 2024

OS Therapies Leading the Way to Breakthroughs in Cancer

OS Therapies Leading the Way to Breakthroughs in Cancer Treatment (NYSE-A: OSTX) ...
Mathew177 - August 14, 2024
View more Bullboard ››

AM Resources Corp

AM Resources Corp

AM Resources Corporation is a Canada-based junior mining company. It specializes in exploration of coal, hydrocarbons and ...
View More »